These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30896149)

  • 1. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.
    Yang L; Liu F; Tong X; Hoffmann D; Zuo J; Lu M
    ACS Infect Dis; 2019 May; 5(5):713-724. PubMed ID: 30896149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Inhibitors of Hepatitis B Virus Nucleocapsid Assembly: A New Approach to Treat Chronic HBV Infection.
    Yang L; Lu M
    Curr Med Chem; 2018; 25(7):802-813. PubMed ID: 28675991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection.
    Cole AG
    Curr Opin Pharmacol; 2016 Oct; 30():131-137. PubMed ID: 27636324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.
    Zhang X; Cheng J; Ma J; Hu Z; Wu S; Hwang N; Kulp J; Du Y; Guo JT; Chang J
    ACS Infect Dis; 2019 May; 5(5):759-768. PubMed ID: 30525438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
    Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
    Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
    Pei Y; Wang C; Yan SF; Liu G
    J Med Chem; 2017 Aug; 60(15):6461-6479. PubMed ID: 28383274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
    Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
    Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Discovery of
    Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core protein.
    Kornyeyev D; Song Z; Eng S; Soulette C; Ramirez R; Tang J; Yue Q; Subramanian R; Zaboli S; Moon C; Tam J; Brodbeck J; Aggarwal A; Diehl L; Fletcher SP; Hyrina A; Holdorf MM; Burdette D
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0042024. PubMed ID: 38780261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B core protein as a therapeutic target.
    Mak LY; Wong DK; Seto WK; Lai CL; Yuen MF
    Expert Opin Ther Targets; 2017 Dec; 21(12):1153-1159. PubMed ID: 29065733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators.
    Nayak S; Gowda J; Abbas SA; Kim H; Han SB
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.
    Kang JA; Kim S; Park M; Park HJ; Kim JH; Park S; Hwang JR; Kim YC; Jun Kim Y; Cho Y; Sun Jin M; Park SG
    Nat Commun; 2019 May; 10(1):2184. PubMed ID: 31097716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of HBV capsid assembly modulators.
    Nijampatnam B; Liotta DC
    Curr Opin Chem Biol; 2019 Jun; 50():73-79. PubMed ID: 30952041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
    Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay.
    Pei Y; Wang C; Ben H; Wang L; Ma Y; Ma Q; Xiang Y; Zhang L; Liu G
    ACS Infect Dis; 2019 May; 5(5):778-787. PubMed ID: 30761887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
    Ruan L; Hadden JA; Zlotnick A
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
    Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
    J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.